The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Effects of nicotinic stimulation on cognitive performance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Working memory: Looking back and looking forward
Baddeley, A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1201 · Cited by 5,200
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · cited 1×
“The P50 inhibition deficit in schizophrenia has been linked to chromosome 15q13–14 in the region of the a7 subunit gene [86].”
BackgroundPhysiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Crook, T., Bartus, R. T., Ferris, S. H., Whitehouse, P., Cohen, G. D., & Gershon, S. (1986) · Developmental Neuropsychology · doi:10.1080/87565648609540348 · Cited by 938
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Sahakian, B., Jones, G., Levy, R., Gray, J., & Warburton, D. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.6.797 · Cited by 494
The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease
Joseph, A. M., Norman, S. M., Ferry, L. H., Prochazka, A. V., Westman, E. C., Steele, B. G., Sherman, S. E., Cleveland, M., Antonuccio, D. O., Hartman, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352402 · Cited by 492
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 486
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479
Jones, G. M. M., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992) · Psychopharmacology · doi:10.1007/bf02247426 · Cited by 476
Lambert, N. M., & Hartsough, C. S. (1998) · Journal of Learning Disabilities · doi:10.1177/002221949803100603 · Cited by 465
Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research
Solanto, M. V. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00431-4 · Cited by 455
Leonard, S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C., Berger, R., Venn, D., Sirota, P., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1085 · Cited by 441
Sofouglu, M., Herman, A. I., Robinson, C. D., & Waters, A. J. (2014) · Lincoln (University of Nebraska) · Cited by 417
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 416
BARKLEY, R. A. (1997) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199708000-00009 · Cited by 415
Overview of nicotinic receptors and their roles in the central nervous system
Dani, J. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01011-8 · Cited by 415
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415
Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Nordberg, A., & Winblad, B. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90629-4 · Cited by 361
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354 · cited 1×
“Epidemiological studies have shown a higher rate of smoking among schizophrenic patients (90%) compared with the general population (20–30%), and a lower rate of smoking cessation among schizophrenic patients [82].”
BackgroundNicotinic receptor subtypes and cognitive function
Levin, E. D. (2002) · Journal of Neurobiology · doi:10.1002/neu.10151 · Cited by 354
Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder
Pomerleau, O. F., Downey, K. K., Stelson, F. W., & Pomerleau, C. S. (1995) · Journal of Substance Abuse · doi:10.1016/0899-3289(95)90030-6 · Cited by 348
Nicotine-Haloperidol Interactions and Cognitive Performance in Schizophrenics
Levin, E. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00018-8 · Cited by 342
Cognitive Mechanisms of Nicotine on Visual Attention
Lawrence, N. S., Ross, T. J., & Stein, E. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)01004-8 · Cited by 322
Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S., & Quirion, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09752.x · Cited by 320
Intravenous nicotine in Alzheimer's disease: a pilot study
Newhouse, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A., & Murphy, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00174504 · Cited by 308
Self-citationPurification and characterization of a nicotinic acetylcholine receptor from rat brain.
Whiting, P., & Lindstrom, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.595 · Cited by 301
Inhibitory control, impulsiveness and attention-deficit hyperactivity disorder
Schachar, R. J., Tannock, R., & Logan, G. (1993) · Clinical Psychology Review · doi:10.1016/s0272-7358(05)80003-0 · Cited by 287
In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs
Schwartz, R. D., & Kellar, K. J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb04005.x · Cited by 285
Flynn, D. D., & Mash, D. C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13113.x · Cited by 285
Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease
White, H. K., & Levin, E. D. (1999) · Psychopharmacology · doi:10.1007/s002130050931 · Cited by 273
Newhouse, P. A., Potter, A., & Levin, E. D. (1997) · Drugs & Aging · doi:10.2165/00002512-199711030-00005 · Cited by 267
Self-citationChanges in Nicotinic and Muscarinic Cholinergic Receptors in Alzheimer‐Type Dementia
Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb12960.x · Cited by 257
Smith, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00324-x · Cited by 247
Akaike, A., Tamura, Y., Yokota, T., Shimohama, S., & Kimura, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91678-0 · Cited by 240
Schwartz, R. D., Lehmann, J., & Kellar, K. J. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb02818.x · Cited by 235
Smoking History and Nicotine Effects on Cognitive Performance
Ernst, M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00257-3 · Cited by 231
Wilens, T. E., Biederman, J., Spencer, T. J., Bostic, J., Prince, J., Monuteaux, M. C., Soriano, J., Fine, C., Abrams, A., Rater, M., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1931 · Cited by 230
Smoking and Parkinson’s disease: A dose–response relationship
Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neurology · doi:10.1212/wnl.52.1.115 · Cited by 224
Smoking and Alzheimer's Disease: A Review of the Epidemiological Evidence
Lee, P. N. (1994) · Neuroepidemiology · doi:10.1159/000110372 · Cited by 206
Effects of Nicotine on Biological Systems II
(1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8 · Cited by 202
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
Perry, E., Martin-Ruiz, C., Lee, M., Griffiths, M., Johnson, M., Piggott, M., Haroutunian, V., Daniel Buxbaum, J., Nãsland, J., Davis, K., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00064-9 · Cited by 201
Gating of auditory P50 in schizophrenics: Unique effects of clozapine
Nagamoto, H. T., Adler, L. E., Hea, R. A., Griffith, J. M., McRae, K. A., & Freedman, R. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00371-1 · Cited by 201
Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety
Wilson, A. L., Langley, L. K., Monley, J., Bauer, T., Rottunda, S., McFalls, E., Kovera, C., & McCarten, J. R. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00043-v · Cited by 197
Rapier, C., Lunt, G. G., & Wonnacott, S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02341.x · Cited by 196
Whitehouse, P. J., Martino, A. M., Wagster, M. V., Price, D. L., Mayeux, R., Atack, J. R., & Kellar, K. J. (1988) · Neurology · doi:10.1212/wnl.38.5.720 · Cited by 185
Pharmacology of Neuronal Nicotinic Acetylcholine Receptor Subtypes
Colquhoun, L. M., & Patrick, J. W. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60072-1 · Cited by 180
The effects of nicotine on Parkinson's disease.
Kelton, M., Kahn, H. J., Conrath, C. L., & NEWHOUSE, P. A. (2000) · PubMed · Cited by 180
Self-citationEffect of nicotine on brain activation during performance of a working memory task
Ernst, M., Matochik, J. A., Heishman, S. J., Van Horn, J. D., Jons, P. H., Henningfield, J. E., & London, E. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061369098 · Cited by 179
Potter, A. S., & Newhouse, P. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1874-y · Cited by 178
Self-citationSmoking and Parkinson's disease.
Godwin-Austen, R. B., Lee, P. N., Marmot, M. G., & Stern, G. M. (1982) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.7.577 · Cited by 175
Electrophysiological actions of nicotine on substantia nigra single units
Clarke, P. B. S., Hommer, D. W., Pert, A., & Skirboll, L. R. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb11081.x · Cited by 169
Potter, A., Corwin, J., Lang, J., Piasecki, M., Lenox, R., & Newhouse, P. A. (1999) · Psychopharmacology · doi:10.1007/s002130050897 · Cited by 163
Self-citationGreenland, S., Satterfield, M. H., & Lanes, S. (1998) · Drug Safety · doi:10.2165/00002018-199818040-00005 · Cited by 162
Nicotine may relieve symptoms of Parkinson's disease
Fagerström, K. O., Pomerleau, O. F., Giordani, B., & Stelson, F. W. (1994) · Psychopharmacology · doi:10.1007/bf02244882 · Cited by 155
Acute nicotinic blockade produces cognitive impairment in normal humans
NEWHOUSE, P. A., Potter, A., Corwin, J., & Lenox, R. H. (1992) · Psychopharmacology · doi:10.1007/bf02247425 · Cited by 148
Self-citationChronic nicotine and locomotor activity: influences of exposure dose and test dose
Ksir, C. J., Hakan, R. L., & Kellar, K. J. (1987) · Psychopharmacology · doi:10.1007/bf00215474 · Cited by 146
Nicotinic treatment of Alzheimer’s disease
Newhouse, P. A., Potter, A., Kelton, M., & Corwin, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01069-6 · Cited by 146
Self-citationvan Duijn, C. M., de Knijff, P., Wehnert, A., Voecht, J. D., Bronzova, J., Havekes, L. M., Albert Hofman, D., & Broeckhoven, C. V. (1995) · Annals of Neurology · doi:10.1002/ana.410370510 · Cited by 144
The separate and combined effects of scopolamine and nicotine on human information processing
Wesnes, K. A., & Revell, A. D. (1984) · Psychopharmacology · doi:10.1007/bf00432014 · Cited by 143
Nicotine and Nicotinic Receptors; Relevance to Parkinson’s Disease
Quik, M., & Kulak, J. M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00036-0 · Cited by 141
Feldon, J., & Weiner, I. (1992) · Journal of Psychiatric Research · doi:10.1016/0022-3956(92)90040-u · Cited by 133
White, H. K., & Levin, E. D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1614-8 · Cited by 121
Cholinergic-dopaminergic interactions in cognitive performance
Levin, E. D., McGurk, S. R., Rose, J. E., & Butcher, L. L. (1990) · Behavioral and Neural Biology · doi:10.1016/0163-1047(90)90639-n · Cited by 110
Bell, S., Taylor, R., Singleton, E., Henningfield, J., & Heishman, S. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011141 · Cited by 107 · cited 8×
“Bell, Taylor, Singleton, Henningfield and Heishman [13] confirmed that smoking deprivation impairs cognitive performance and that re-administering cigarettes briskly relieves this performance decrement.”
BackgroundInfluentialEffects of nicotine gum on repeated administration of the stroop test
Provost, S., & Woodward, R. (1991) · Psychopharmacology · doi:10.1007/bf02245662 · Cited by 105
Concepts of mild memory impairment in the elderly and their relationship to dementia—a review
Dawe, B., PROCTER, A. W., & Philpot, M. P. (1992) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930070704 · Cited by 100
Knott, V., Bosman, M., Mahoney, C., Ilivitsky, V., & Quirt, K. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00006-4 · Cited by 94
Heishman, S. J., & Henningfield, J. E. (2000) · Psychopharmacology · doi:10.1007/s002130000541 · Cited by 94
Development of ligands for in vivo imaging of cerebral nicotinic receptors
Sihver, W., Nordberg, A. K., Långström, B., Mukhin, A. G., Koren, A. O., Kimes, A. S., & London, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00209-6 · Cited by 86
Cholinergic Control of Cognitive Resources
Warburton, D. M., & Rusted, J. M. (2008) · Neuropsychobiology · doi:10.1159/000118998 · Cited by 85
The short-term effect of nicotine chewing gum in patients with parkinson's disease
Clemens, P., Baron, J. A., Coffey, D., & Reeves, A. G. (1995) · Psychopharmacology · doi:10.1007/bf02245195 · Cited by 84
Transdermal nicotine: reduction of smoking with minimal abuse liability
Pickworth, W. B., Bunker, E. B., & Henningfield, J. E. (1994) · Psychopharmacology · doi:10.1007/bf02244745 · Cited by 83
Baseline-dependency of nicotine effects: a review
Perkins, K. A. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00006 · Cited by 79
van der Meere, J., Gunning, B. W., & Stemerdink, N. B. A. (1999) · Journal of Child Psychology and Psychiatry · doi:10.1017/s0021963098003424 · Cited by 77
Schneider, J. S., Velson, M. V., Menzaghi, F., & Lloyd, G. K. (1998) · Annals of Neurology · doi:10.1002/ana.410430308 · Cited by 69
Improvements in performance without nicotine withdrawal
Warburton, D. M., & Arnall, C. (1994) · Psychopharmacology · doi:10.1007/bf02245578 · Cited by 66
Psychoactive Drugs and Pilot Performance: A Comparison of Nicotine, Donepezil, and Alcohol Effects
Mumenthaler, M. S., Yesavage, J. A., Taylor, J. L., O'Hara, R. M., Friedman, L., Lee, H., & KRAEMER, H. C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300202 · Cited by 65
Fluoro-norchloroepibatidine: Preclinical assessment of acute toxicity
Molina, P. E., Ding, Y., Carroll, F. I., Liang, F., Volkow, N. D., Pappas, N. R., Kuhar, M. J., Abumrad, N. N., Gatley, S. J., & Fowler, J. S. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00120-0 · Cited by 63
Fujita, M., Seibyl, J. P., Vaupel, B. D., Tamagnan, G., Early, M., Zoghbi, S. S., Baldwin, R. M., Horti, A. G., Koren, A. O., Mukhin, A. G., et al. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0695-z · Cited by 62
Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist
Sacaan, A. I., Reid, R. T., Santori, E. M., Adams, P., Correa, L. D., Mahaffy, L. S., Bleicher, L. S., Cosford, N. D. P., Stauderman, K. A., McDonald, I. A., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36402-x · Cited by 60
Musachio, J. L., Villemagne, V. L., Scheffel, U., Stathis, M. J., Finley, P. A., Horti, A. G., London, E. D., & Dannals, R. F. (1997) · Synapse · Cited by 54
Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors.
Horti, A. G., Scheffel, U., Stathis, M. J., Finley, P. A., Ravert, H. T., London, E. D., & Dannals, R. F. (1997) · PubMed · Cited by 54
Intravenous Nicotine Reduces Cerebral Glucose Metabolism: A Preliminary Study
Stapleton, J. M., Gilson, S. F., Wong, D. F., Villemagne, V. L., Dannals, R. F., GRAYSON, R. F., Henningfield, J. E., & London, E. D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300106 · Cited by 52
Tyas, S. L. (1996) · Addiction Biology · doi:10.1080/1355621961000124856 · Cited by 49
Effects of smoking status and schizotypy on latent inhibition
Casa, V. D., Höfer, I., Weiner, I., & Feldon, J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300106 · Cited by 45
Menzaghi, F., Whelan, K. T., Risbrough, V. B., Rao, T. S., & Lloyd, G. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36404-3 · Cited by 43
The Effects of Nicotine in Dermal Plaster on Cognitive Functions in Patients with Alzheimers Disease
Snædal, J., Jóhannesson, T., Jonsson, J., & Gylfadottir, G. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106852 · Cited by 43
Acute effects of cigarettes in non‐deprived smokers on memory, calculation and executive functions
Sakurai, Y., & Kanazawa, I. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.424 · Cited by 41
Presynaptic nicotinic acetylcholine receptors in the brain
Wonnacott, S., Soliakov, L. S., Wilkie, G., Redfern, P. H., & Marshall, D. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4<149::aid-ddr3>3.0.co;2-m · Cited by 41
Does nicotine improve cognitive function?
Rusted, J. M., Graupner, L., O'Connell, N., & Nicholls, C. (1994) · Psychopharmacology · doi:10.1007/bf02245580 · Cited by 39
Effects of nicotine chewing gum on UPDRS score and P300 in early-onset parkinsonism.
Mitsuoka, T., Kaseda, Y., Yamashita, H., Kohriyama, T., Kawakami, H., Nakamura, S., & Yamamura, Y. (2002) · PubMed · Cited by 33
Knott, V., Mohr, E., Mahoney, C., Engeland, C. G., & Ilivitsky, V. (2002) · Neuropsychobiology · doi:10.1159/000054957 · Cited by 26
Sihver, W., Fasth, K., Horti, A. G., Koren, A. O., Bergström, M., Lu, L., Hagberg, G. E., Lundqvist, H., Dannals, R. F., London, E. D., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731264.x · Cited by 25
Effects of the nicotine patch on performance during the first week of smoking cessation
Cook, M., Gerkovich, M. M., Graham, C., Hoffman, S., & Peterson, R. C. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220031000074873 · Cited by 21
Effects of a low dose of transdermal nicotine on information processing
Davranche, K., & Audiffren, M. F. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210141635 · Cited by 18
[ 125/123 I] 5-Iodo-3-pyridyl ethers
Fan, H. S., Scheffel, U., Rauseo, P., Xiao, Y., Dogan, A. S., Yokoi, F., Hilton, J., Kellar, K. J., Wong, D. F., & Musachio, J. L. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00258-x · Cited by 16
Cited by
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
“Further studies with nicotinic drugs specific for nicotinic receptor subtypes may offer promising leads for treating cognitive dysfunction (Levin and Rezvani 2002; Newhouse et al. 2004).”
BackgroundCognitive Enhancement: Methods, Ethics, Regulatory Challenges
Bostrom, N., & Sandberg, A. (2009) · Science and Engineering Ethics · doi:10.1007/s11948-009-9142-5 · Cited by 741
Modes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Resting state functional connectivity in addiction: Lessons learned and a road ahead
Sutherland, M. T., McHugh, M. J., Pariyadath, V., & Stein, E. A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.117 · Cited by 494
Metadata
- Authors
- Newhouse, P.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 4
- Issue
- 1
- Pages
- 36-46
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2057196462
- Cited by
- 405
- References
- 105
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.